Prognostic value of memory B cell subpopulation in patients with chronic lymphocytic leukemia
Clinical and Experimental Medicine · 2025
DOI: 10.1007/s10238-025-02002-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Medicine, 2025. Verfasst von Aviwe Ntsethe und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Physiology, Nelson Mandela University, Private Bag X77000, Gqeberha, 6031, South Africa. aviwe.ntsethe@mandela.ac.za. Hauptthemen laut MEDLINE: Leukemia, Lymphocytic, Chronic, B-Cell, Memory B Cells. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Chronic lymphocytic leukemia (CLL) is characterized by aberrant B-cell receptor (BCR) signalling and resistance to apoptosis. Patients with CLL present varied responses to BCR-targeted therapies, this emphasises the need for personalised treatment strategies. The immunophenotype of B cell in patients with CLL may offer valuable insights into disease heterogeneity and immunotherapeutic strategies. In this study, we investigated the prognostic value of B cell subsets in relation to clinical parameters such as Rai stage, β₂-microglobulin (B2M) levels and the Chronic Lymphocytic Leukemia International Prognostic Index (CLL-IPI) in untreated patients with CLL. The levels B cell subsets were measured using multicolor flow cytometry. Interestingly, patients with CLL had significantly increased levels of naïve B cells (p < 0.0001). As expected, patients with CLL had significantly decreased levels of marginal zone B cells (p = 0.0059), non-class switched memory B cells (p = 0.0010), and class switched memory B cells (p < 0.0001). Moreover, after adjusting for age and sex, class-switched memory B cells were positively associated with the Rai stage (β = 0.1455, p = 0.0466). In contrast, non-class switched memory B cells inversely correlated with the Chronic Lymphocytic Leukemia International Prognostic Index (r = -0.79, p = 0.004). These findings suggest that memory B-cell subset profiles may provide valuable prognostic significance in patients with CLL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Human Physiology, Nelson Mandela University, Private Bag X77000, Gqeberha, 6031, South Africa. aviwe.ntsethe@mandela.ac.za.
- School of Laboratory Medicine and Medical Sciences (SLMMS), College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.
Zitieren
APA
Ntsethe, A., & Nkambule, B. B. (2025). Prognostic value of memory B cell subpopulation in patients with chronic lymphocytic leukemia. Clinical and Experimental Medicine. https://doi.org/10.1007/s10238-025-02002-5
Vancouver
Ntsethe A, Nkambule BB. Prognostic value of memory B cell subpopulation in patients with chronic lymphocytic leukemia. Clinical and Experimental Medicine. 2025. doi:10.1007/s10238-025-02002-5
BibTeX
@article{Ntsethe2025,
author = {Ntsethe, Aviwe and Nkambule, Bongani Brian},
title = {Prognostic value of memory B cell subpopulation in patients with chronic lymphocytic leukemia},
journal = {Clinical and Experimental Medicine},
year = {2025},
doi = {10.1007/s10238-025-02002-5}
}
EUVIMED